Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
Pre-emptive targeted and optimized treatment of critical airway colonization to prevent Ventilator Associated Pneumonia: a randomized controlled study Trattamento precoce mirato e ottimizzato della colonizzazione critica delle vie aeree per prevenire la Polmonite associata a ventilazione meccanica: studio randomizzato controllato
to assess whether targeted pre-emptive therapy (based on isolates obtained from quantitative screening for colonization of lower respiratory airways) reduces VAP (see Annex 1) occurrence when compared...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
A Phase II Study of Panitumumab 5-Fluorouracil and Oxaliplatin in combination with pelvic radiotherapy as treatment of resectable and locally advanced rectal cancer (StarPan Study ヨ STAR 02)
To assess the complete pathological response rate over the treatment period when panitumumab, 5-fluorouracil and oxaliplatin are administered in combination with external beam radiotherapy in Subjec...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
Treatment with leucocytic interferon-alpha more ribavirine towards peg-interferon to reduced doses more ribavirine in patients affections from positive chronic hepatitis HCV that in course of arranged therapy demand the reduction of the peghilato dosage of interferon
To estimate if, in the patients who in course of arranged therapy manifest abnormality of laboratory or adverse events, the passage to an other type of interferon concurs the completion of the therapy...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
RANDOMIZED CLINICAL STUDY OF DIFFERENT DOSES And DURATION OF PARNAPARINA In the TREATMENT Of SUPERFICIAL VENOUS THROMBOSIS - STEFLUX STUDY
To evaluate the efficacy and the safety of three different plans, different for duration and dose, of parnaparina in the treatment of the superficial venous thromboses of the inferior limbs.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 5 ans
A PHASE II, OPEN-LABEL, PROSPECTIVE, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBSEQUENT TREATMENT WITH THE ZEVALIN (IBRITUMOMAB TIUXETAN) IN ELDERLY ( 60 YEARS) PATIENTS WITH DIFFUSE LARGE BCELL LYMPHOMA AFTER 4 CYCLES OF CHOP21 ヨRITUXIMAB (CHOP21-R) THERAPY
Evaluation of efficacy and safety of [90Y]-ibritumomab tiuxetan, as well as assessment of quality of life
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
Phase II study of Proteasome inhibitor Bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma unspecified PTCLU and cutaneous T-cell lymphoma CTCL
to assess the feasibility of Bortezomib as salvage treatment
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
High dose atorvastatin in acute ischemic stroke Monocenter pilot study
To show favorable effects of the early administration of atorvastatin 80 mg/day in acute ischemic stroke, on the short term development of neurological deficit and extension of brain lesion, and on th...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
Role of 64Cu-ATSM PET/CT for the localization of hypoxic areas in uterine cervical cancer
The main aim of this study is the evaluation of 64Cu-ATSM PET/CT sensitivity for localizing area of hypoxia within tumoral masses.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy in Percutaneous Coronary Intervention
Aim of this study is to evaluate safety and efficacy of Iloprost in protecting coronary microcirculation during percutaneous angioplasty thanks to the action of Iloprost against vasoactive substances...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
Effetti della iniezione endovitreale di Avastin per il trattamento delle maculopatie essudative
Utilizzo di un inibitore dell’angiogenesi di provata efficacia nell’uomo in pazienti affetti da maculopatie la cui origine e' legata ad una anomala produzione di fattori di crescita endoteliali nel ca...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
5
6
7
8
9
10
Suivant